Hosted on MSN
MTVA: DA-1241 in Combination with Efruxifermin Shows Additive Hepatoprotective Effects in Mouse MASH Model…
DA-1241 in Combination with Efruxifermin Shows Enhanced Hepatoprotective Effects On June 21, 2025, MetaVia Inc. (NASDAQ:MTVA) announced the presentation of preclinical data for DA-1241, the company’s ...
Recently presented preclinical data show that EA Pharma Co. Ltd.'s EA-3571 is a highly potent dual inhibitor of enteropeptidase and trypsin with luminal action, resulting in potential anti-insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback